Author: Leigh MacMillan
Long antibodies better against HIV
Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.
VU study finds stress fuels breast cancer metastasis to bone
Jul. 18, 2012—Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered.
Insights for neuroscience drug discovery
Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
Receptor’s role in nutrition brain circuitry
Jul. 3, 2012—New findings point to brain circuitry that communicates about the body’s nutritional status and regulates how nutrients are mobilized.
Low oxygen could protect sick kidneys
Jun. 28, 2012—Low oxygen – and the activation of factors that respond to this situation – may be protective in chronic kidney disease.
Roots of childhood brain tumors
Jun. 14, 2012—Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.
DNA: From modification to mutation
Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.
Alzheimer’s protein structure suggests new treatment directions
May. 31, 2012—The molecular structure of a protein involved in Alzheimer’s disease – and the surprising discovery that it binds cholesterol – could lead to new therapeutics for the memory-robbing disease.
Long live the therapeutic stem cells
May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
Intestinal artillery launches anti-bacterial attack
May. 14, 2012—The epithelial cells that line the intestines have a newly discovered mechanism for protecting us against microbes: they fire anti-bacterial "bullets" into the gut.
Probing epilepsy’s molecular sparks
May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
Better blood pressure-reducing drugs?
Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.